Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Express Scripts
McKesson
Mallinckrodt
McKinsey

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

SORBITOL 3.3% IN PLASTIC CONTAINER Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Sorbitol 3.3% In Plastic Container patents expire, and what generic alternatives are available?

Sorbitol 3.3% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in SORBITOL 3.3% IN PLASTIC CONTAINER is sorbitol. There are ten drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sorbitol profile page.

Summary for SORBITOL 3.3% IN PLASTIC CONTAINER
Drug patent expirations by year for SORBITOL 3.3% IN PLASTIC CONTAINER
Recent Clinical Trials for SORBITOL 3.3% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alanya Alaaddin Keykubat UniversityPhase 2
ScandiBio Therapeutics ABPhase 2
KTH Royal Institute of TechnologyPhase 2

See all SORBITOL 3.3% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for SORBITOL 3.3% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun SORBITOL 3.3% IN PLASTIC CONTAINER sorbitol SOLUTION;IRRIGATION 016741-001 Approved Prior to Jan 1, 1982 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Johnson and Johnson
Moodys
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.